-
RheinCell Therapeutics Achieves GMP Certification
contractpharma
January 15, 2021
RheinCell Therapeutics GmbH, a developer and manufacturer of human induced pluripotent stem cells (iPSCs) as starting materials for cell therapies, has received Good Manufacturing Practice (GMP) certification and Manufacturing Authorization.
-
LASA gets WHO GMP certificate for Khed Unit in Ratnagiri
expresspharma
January 13, 2021
WHO GMP covers all aspects of production starting from the materials, premises and equipment to the training and personal hygiene of staff.
-
Abzena Unveils New Biologics GMP Manufacturing Site
contractpharma
January 12, 2021
Abzena, a global partner research organization for integrated bench to market solutions for biologics and bioconjugates, has added a sixth global site that will augment cGMP manufacturing capacity for mammalian biologics.
-
Lipidor signs cooperation agreement with contract manufacturer to offer licensees the opportunity for GMP production
prnasia
December 17, 2020
Lipidor AB announced that the Company has signed a new cooperation agreement with Aurena Laboratories AB. Over a five-year period, Lipidor will invest up to SEK 15 million in the new collaboration.
-
Recipharm Expands API Manufacturing Capabilities
contractpharma
December 10, 2020
Global contract development and manufacturing organization (CDMO), Recipharm, has unveiled an investment and capacity expansion at its facility in Israel.
-
Abenza Upgrades Chemistry GMP Suites
contractpharma
November 25, 2020
Abzena, a global partner research organization for integrated bench to market solutions for biologics and bioconjugates, has announced upgrades of its chemistry GMP suites.
-
CordenPharma Expands Peptide Development Capacity
contractpharma
November 19, 2020
CordenPharma’s Centre of Excellence for Peptide Process Development and non-GMP manufacturing in Frankfurt, Germany is not only known for bringing a high level of peptide expertise in the development of efficient and lean peptide processes like ...
-
Eurofins CDMO Expands Drug Product Capabilities in Canada
contractpharma
November 06, 2020
Eurofins CDMO has expanded its existing drug product operation capabilities with the early 2020 completion of its new drug product development and cGMP manufacturing facility, located in Mississauga, Canada.
-
eTheRNA Extends mRNA Production Services
contractpharma
November 05, 2020
In response to growing international demand, eTheRNA has extended its mRNA production services to include high throughput research grade mRNA in addition to its GMP capabilities.
-
Valicare Expands Service Portfolio
contractpharma
October 29, 2020
Valicare GmbH, a wholly owned subsidiary of Syntegon, now offers additional services along the entire product life cycle of pharmaceutically and biotechnologically produced drugs.